F.A.Q.
What kind of studies are conducted at Altorithme Pharma?
For over 10 years now, Algorithme Pharma conducts two types of studies : Bioequivalence & Phase I. Bioequivalence consists of comparing two similar medications, one of which is already available on the market, while Phase I studies contribute to the development of new medications.
What about side effects?
Are there side effects? Yes there might be side effects. Although, in general, the goal of the study is not to see if the drug works, but rather to see if it is an equivalent copy of the original drug that is already on the market; during the course of the study you might experience some discomfort. Rest assured that we have nurses and/or doctors available on location to make sure that if you experience any side effects you will receive the proper care.
How do I know that Algorithme Pharma is a credible company?
Algorithme Pharma has been successfully audited by:
- The United States Food and Drug Administration (FDA)
- Health Canada's Therapeutic Product's Directorate (TPD)
- the Brazilian National Health Surveilance Agency (ANVISA)
- the French Health Products Safety Agency (AFSSAPS)
This means that these government bodies have inspected Algorithme Pharma’s sites and have approved their procedures according to their laws and guidelines. Algorithme Pharma’s exceptional track record and reputation are proof that we will never compromise our ways of doing things. Knowing that you are dealing with recognized professionals should be important to you.
What will be my compensation?
Study volunteers can receive up to $1500, sometimes more. The level of compensation is based on the amount of time spent in the clinic, the number of follow-up visits and the type of study (duration, number of stays, number of samples).
If you have any more questions on our clinical trials call one of our Call-Center agents today at